You need to enable JavaScript to run this app.
Regulatory Recon: NIH Refuses to 'March-In' on Xtandi Billionaire Sean Parker Funds First In-Human CRISPR Trial (21 June 2016)
Recon
Regulatory News
Michael Mezher